Jean Ducobu

1.3k total citations
68 papers, 690 citations indexed

About

Jean Ducobu is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Immunology. According to data from OpenAlex, Jean Ducobu has authored 68 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Surgery and 14 papers in Immunology. Recurrent topics in Jean Ducobu's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (12 papers), Lipoproteins and Cardiovascular Health (12 papers) and Nitric Oxide and Endothelin Effects (7 papers). Jean Ducobu is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (12 papers), Lipoproteins and Cardiovascular Health (12 papers) and Nitric Oxide and Endothelin Effects (7 papers). Jean Ducobu collaborates with scholars based in Belgium, Poland and United States. Jean Ducobu's co-authors include Michel Vanhaeverbeek, Karim Zouaoui Boudjeltia, Nicole Moguilevsky, Pierre Van Antwerpen, P. Delrée, Jean Nève, Dany Brohée, Michel Farnier, Leszek Bryniarski and Claude Remacle and has published in prestigious journals such as PLoS ONE, Analytical Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Jean Ducobu

65 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jean Ducobu Belgium	16	222	157	138	114	96	68	690
Serge Simonet France	17	133 0.6×	80 0.5×	112 0.8×	342 3.0×	237 2.5×	39	842
Murat Giriş Türkiye	18	70 0.3×	169 1.1×	148 1.1×	123 1.1×	190 2.0×	35	836
Paula Maldonado Brazil	17	316 1.4×	44 0.3×	78 0.6×	81 0.7×	240 2.5×	37	943
Averil Y. Warren United Kingdom	24	211 1.0×	61 0.4×	42 0.3×	132 1.2×	318 3.3×	42	1.2k
Pablo Stiefel Spain	18	54 0.2×	165 1.1×	177 1.3×	150 1.3×	150 1.6×	60	927
Kenneth B. Pomerantz United States	19	189 0.9×	253 1.6×	261 1.9×	222 1.9×	361 3.8×	37	1.2k
Predrag Vlahović Serbia	19	47 0.2×	162 1.0×	107 0.8×	96 0.8×	172 1.8×	65	781
Mohammad N Uddin United States	21	240 1.1×	210 1.3×	85 0.6×	69 0.6×	329 3.4×	55	1.1k
Cemil Bilir Türkiye	13	78 0.4×	70 0.4×	47 0.3×	82 0.7×	174 1.8×	53	571
L. Daffonchio Italy	18	152 0.7×	77 0.5×	143 1.0×	405 3.6×	176 1.8×	65	932

Countries citing papers authored by Jean Ducobu

Since Specialization

Citations

This map shows the geographic impact of Jean Ducobu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Ducobu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Ducobu more than expected).

Fields of papers citing papers by Jean Ducobu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Ducobu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Ducobu. The network helps show where Jean Ducobu may publish in the future.

Co-authorship network of co-authors of Jean Ducobu

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Ducobu. A scholar is included among the top collaborators of Jean Ducobu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Ducobu. Jean Ducobu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boudjeltia, Karim Zouaoui, Pierre Van Antwerpen, Nicole Moguilevsky, et al.. (2012). Exposure of Endothelial Cells to Physiological Levels of Myeloperoxidase-Modified LDL Delays Pericellular Fibrinolysis. PLoS ONE. 7(6). e38810–e38810. 18 indexed citations

Farnier, Michel, Jean Ducobu, Armin Steinmetz, et al.. (2012). Safety of a Fixed-Dose Combination of Fenofibrate/Pravastatin 160 mg/40 mg in Patients with Mixed Hyperlipidaemia. Clinical Drug Investigation. 32(4). 281–291. 8 indexed citations

Delporte, Cédric, Pierre Van Antwerpen, Karim Zouaoui Boudjeltia, et al.. (2010). Optimization of apolipoprotein-B-100 sequence coverage by liquid chromatography–tandem mass spectrometry for the future study of its posttranslational modifications. Analytical Biochemistry. 411(1). 129–138. 5 indexed citations

Farnier, Michel, Jean Ducobu, & Leszek Bryniarski. (2010). Efficacy and Safety of Adding Fenofibrate 160 mg in High-Risk Patients With Mixed Hyperlipidemia Not Controlled by Pravastatin 40 mg monotherapy. The American Journal of Cardiology. 106(6). 787–792. 26 indexed citations

Roumeguère, Thierry, Karim Zouaoui Boudjeltia, Vincent Nuyens, et al.. (2009). Effects of Phosphodiesterase Inhibitors on the Inflammatory Response of Endothelial Cells Stimulated by Myeloperoxidase-Modified Low-Density Lipoprotein or Tumor Necrosis Factor Alpha. European Urology. 57(3). 522–529. 31 indexed citations

Aminian, Adel, Karim Zouaoui Boudjeltia, Pierre Van Antwerpen, et al.. (2009). Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction. European Journal of Internal Medicine. 20(5). 527–532. 11 indexed citations

Roumeguère, Thierry, Karim Zouaoui Boudjeltia, C. Schulman, et al.. (2008). Diminution du rapport ApoB/ApoA-1 et amélioration du risque cardiovasculaire : effet pleïotropique du tadalafil ? Étude préliminaire sur volontaires sains. Progrès en Urologie. 18(13). 1087–1091. 3 indexed citations

Ducobu, Jean, et al.. (2007). Efficacy of atorvastatin after LDL-cholesterol-based dose selection in high risk dyslipidaemic patients: results of the target dose study. Current Medical Research and Opinion. 23(8). 1821–1827. 7 indexed citations

Boudjeltia, Karim Zouaoui, Dany Brohée, Vincent Nuyens, et al.. (2007). Monocyte–platelet complexes on CD14/CD16 monocyte subsets: relationship with ApoA-I levels. A preliminary study. Cardiovascular Pathology. 17(5). 285–288. 4 indexed citations

10.

Boudjeltia, Karim Zouaoui, Thierry Roumeguère, P. Delrée, et al.. (2006). Presence of LDL Modified by Myeloperoxidase in the Penis in Patients with Vascular Erectile Dysfunction: A Preliminary Study. European Urology. 51(1). 262–269. 19 indexed citations

11.

Boudjeltia, Karim Zouaoui, Michel Guillaume, P. Delrée, et al.. (2006). Fibrinolysis and cardiovascular risk factors: Association with fibrinogen, lipids, and monocyte count. European Journal of Internal Medicine. 17(2). 102–108. 13 indexed citations

12.

Antwerpen, Pierre Van, Karim Zouaoui Boudjeltia, Patrick Moreau, et al.. (2006). Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors. European Journal of Pharmacology. 537(1-3). 31–36. 9 indexed citations

13.

Ducobu, Jean & J Sternon. (2005). Le rimonabant (Acomplia®), inhibiteur spécifique du système endocannabinoïde. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 26(3). 165–168. 1 indexed citations

14.

Antwerpen, Pierre Van, Karim Zouaoui Boudjeltia, Patrick Moreau, et al.. (2005). Thiol-containing molecules interact with the myeloperoxidase/H2O2/chloride system to inhibit LDL oxidation. Biochemical and Biophysical Research Communications. 337(1). 82–88. 39 indexed citations

15.

Scruel, Olivier, et al.. (2005). Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin. International Journal of Cardiology. 104(3). 338–345. 21 indexed citations

16.

Ducobu, Jean. (2005). La prise en charge globale des facteurs de risque cardiovasculaire chez le diabétique. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 26(4). 1 indexed citations

17.

Ducobu, Jean, et al.. (2003). Comparison of Micronized Fenofibrate and Pravastatin in Patients With Primary Hyperlipidemia. Journal of Cardiovascular Pharmacology. 41(1). 60–67. 10 indexed citations

18.

Ducobu, Jean & J Sternon. (2000). Les glitazones (thiazolidinediones). Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 21(5). 441–446. 2 indexed citations

19.

Crenier, Laurent, et al.. (1996). Low response to high‐dose intravenous immunoglobulin in the treatment of acquired factor VIII inhibitor. British Journal of Haematology. 95(4). 750–753. 31 indexed citations

20.

Tonacchera, Massimo, Sabine Costagliola, Filomena Cetani, et al.. (1996). Patient with monoclonal gammopathy, thyrotoxicosis, pretibial myxedema and thyroid-associated ophthalmopathy; demonstration of direct binding of autoantibodies to the thyrotropin receptor. European Journal of Endocrinology. 134(1). 97–103. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact